2nd Quarter - Report

THE NICKLES GROUP, LLC for MERCK & CO. INC.

Period 2nd Quarter 2018 Filed Jul 20, 2018 Signed by Stacey Hughes

Official filing
Firm
THE NICKLES GROUP, LLC
Client
MERCK & CO. INC.
Income
$45,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to drug pricing and the Medicare Part D program.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA)

Health Issues HCR

Issues related to antimicrobials; issues related to the reauthorization of PAHPA; monitored issues related to the Right to Try Act of 2018; H.R. 5599, Animal Health and Innovation Act; H.R. 5554, The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (ADUFA) and (AGDUFA). Issues regarding drug pricing.

LobbyistCovered position, as disclosed
STEPHANIE BADGER New —
STACEY HUGHES —
EMILY PORTER —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5599 (115th), H.R. 5554 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.